Skip to Main Content

Paper Details

Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better.
Journal for ImmunoTherapy of Cancer
23
2022
ICB, TMB, Tumor, bladder cancer, cancer, cancer of, colorectal cancer, melanoma, non-small cell lung cancer, patients, tumors
Author NameAffiliation
Ming ZhengInstitute of Military Cognition and Brain Sciences, Academy of Military Medical Sciences
Ming ZhengBeijing Institute of Basic Medical Sciences
  • 1 - 2

Datasets

Release 1.2